Literature DB >> 16187746

No major role for 7,8-dihydro-8-oxoguanine in ultraviolet light-induced mutagenesis.

Ulrike P Kappes1, Thomas M Rünger.   

Abstract

Oxidative DNA damage, in particular 7,8-dihydro-8-oxoguanine (8-oxoG), has been suggested to mediate mutation formation and malignant transformation after exposure of the skin to long-wave ultraviolet (UVA) light. It is processed primarily by the base excision repair (BER) pathway. The initial step of BER is the removal of the damaged base by a damage-specific DNA-glycosylase, which is 8-oxoG DNA glycosylase (OGG1) for 8-oxoG. To study the contribution of 8-oxoG to UVA-light mutagenesis, we compared UVA- and UVB-light-induced mutation frequencies in mouse embryonal fibroblasts from OGG1 knockout mice and their OGG1-intact littermates using the ouabain mutagenesis assay. After irradiation with various doses of UVA or UVB radiation, mutations in the Na,K-ATPase gene of single cells were detected by testing for colony-forming ability in a selective medium. OGG1-/- cells did not exhibit an increased frequency of UV-light-induced mutations compared to OGG1+/+ cells after exposure to either UVA or UVB radiation. This indicates that 8-oxoG, which is processed by OGG1, does not contribute significantly to either UVA- or UVB-light-induced mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187746     DOI: 10.1667/rr3434.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  Mutagenicity of ultraviolet A radiation in the lacI transgene in Big Blue mouse embryonic fibroblasts.

Authors:  Sang-in Kim; Gerd P Pfeifer; Ahmad Besaratinia
Journal:  Mutat Res       Date:  2007-01-10       Impact factor: 2.433

2.  Long-wavelength UVA enhances UVB-induced cell death in cultured keratinocytes: DSB formation and suppressed survival pathway.

Authors:  Yuko Ibuki; Yukako Komaki; Guang Yang; Tatsushi Toyooka
Journal:  Photochem Photobiol Sci       Date:  2021-05-12       Impact factor: 3.982

3.  Wavelength dependence of ultraviolet radiation-induced DNA damage as determined by laser irradiation suggests that cyclobutane pyrimidine dimers are the principal DNA lesions produced by terrestrial sunlight.

Authors:  Ahmad Besaratinia; Jae-In Yoon; Christi Schroeder; Stephen E Bradforth; Myles Cockburn; Gerd P Pfeifer
Journal:  FASEB J       Date:  2011-05-25       Impact factor: 5.191

4.  Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation.

Authors:  Stéphane Mouret; Caroline Baudouin; Marie Charveron; Alain Favier; Jean Cadet; Thierry Douki
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

5.  Riboflavin activated by ultraviolet A1 irradiation induces oxidative DNA damage-mediated mutations inhibited by vitamin C.

Authors:  Ahmad Besaratinia; Sang-In Kim; Steven E Bates; Gerd P Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

6.  Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress.

Authors:  Soumita Das; Ranajoy Chattopadhyay; Kishor K Bhakat; Istvan Boldogh; Kimitoshi Kohno; Rajendra Prasad; Samuel H Wilson; Tapas K Hazra
Journal:  J Biol Chem       Date:  2007-08-07       Impact factor: 5.157

7.  Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells.

Authors:  Ahmad Besaratinia; Sang-In Kim; Gerd P Pfeifer
Journal:  FASEB J       Date:  2008-03-07       Impact factor: 5.191

8.  Whole-exome sequencing reveals the impact of UVA light mutagenesis in xeroderma pigmentosum variant human cells.

Authors:  Natália Cestari Moreno; Tiago Antonio de Souza; Camila Carrião Machado Garcia; Nathalia Quintero Ruiz; Camila Corradi; Ligia Pereira Castro; Veridiana Munford; Susan Ienne; Ludmil B Alexandrov; Carlos Frederico Martins Menck
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.